Qiagen

Update in progress

QGEN (NYSE)

Company RatingNeutral
SectorHealthcare
IndustryDiagnostics & Research

QIAGEN N.V. provides sample-to-insight solutions that transform biological samples into molecular information. It offers sample technology consumables for stabilization, purification, and automated processing for genotyping, gene expression, and viral and bacterial analysis, plus silica membranes, magnetic beads, secondary consumables, and purification instruments. It supplies immune, oncology, reproductive health, prenatal, STI, and genomic variant assays, NGS panels and library prep, DNA methylation analysis, bioinformatics, and SaaS. Founded 1984, based in Venlo, Netherlands.

Company score

Sentiment: 0.23; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.42; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: -0.03; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.00; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.13; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.18; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive